{
    "id": "5e476da1d14c9f295d000002",
    "question": "Is marimastat effective for small-cell lung cancer?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine whether marimastat is effective for small-cell lung cancer, we need to consider its mechanism of action and clinical trial data. Marimastat is a serine protease inhibitor that targets the angiogenesis pathway, which is crucial for tumor growth and metastasis. Small-cell lung cancer is an aggressive type of lung cancer that is known for its rapid growth and metastasis. The efficacy of marimastat in small-cell lung cancer has been investigated in several clinical trials. The results have been mixed, but some studies have shown that marimastat can slow down tumor growth and improve survival in patients with small-cell lung cancer. However, the overall evidence is not conclusive, and more research is needed to fully understand its effectiveness. Therefore, the answer to whether marimastat is effective for small-cell lung cancer is not straightforward. That being said, based on the available data, I would lean towards option A, yes, but with the understanding that the evidence is not yet definitive and more research is needed to confirm its effectiveness.\"} \"answer_choice\": \"A\"",
    "snippets": [],
    "scores": [],
    "execution_time": 40.837064027786255
}